Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.27B | 2.33B | 2.33B | 2.70B | 2.86B |
Gross Profit | 1.20B | 1.21B | 1.14B | 1.33B | 1.22B |
EBITDA | 122.51M | 299.51M | 85.11M | 139.85M | -3.76M |
Net Income | 30.95M | 39.57M | 12.43M | -89.68M | -301.35M |
Balance Sheet | |||||
Total Assets | 2.61B | 3.01B | 3.52B | 3.02B | 3.22B |
Cash, Cash Equivalents and Short-Term Investments | 186.89M | 192.42M | 252.19M | 677.23M | 771.69M |
Total Debt | 1.12B | 1.45B | 1.97B | 1.30B | 1.25B |
Total Liabilities | 1.88B | 2.30B | 2.83B | 2.28B | 2.41B |
Stockholders Equity | 735.49M | 710.80M | 684.40M | 733.32M | 814.33M |
Cash Flow | |||||
Free Cash Flow | 38.85M | 212.00M | 130.62M | 28.05M | 114.24M |
Operating Cash Flow | 171.68M | 297.78M | 244.71M | 177.73M | 246.58M |
Investing Cash Flow | -106.38M | -114.11M | -126.09M | -169.15M | -140.51M |
Financing Cash Flow | -69.03M | -242.27M | -563.79M | -97.40M | -141.76M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
67 Neutral | ¥252.23B | 13.18 | 6.50% | 2.78% | 5.06% | -11.83% | |
61 Neutral | HK$418.00M | 12.36 | 4.29% | ― | -4.28% | -25.99% | |
$38.59M | ― | -90.66% | ― | ― | ― | ||
64 Neutral | HK$149.28M | 642.86 | 0.05% | 11.11% | -5.58% | -91.36% | |
48 Neutral | HK$90.38M | 7.74 | 6.87% | ― | -7.14% | -110.87% | |
46 Neutral | HK$313.60M | ― | -18.04% | ― | -42.38% | 28.61% | |
46 Neutral | HK$92.00M | ― | -40.69% | ― | -6.89% | -356.53% |
Mulsanne Group Holding Limited has established a Nomination Committee as part of its corporate governance structure, which is mandated by a resolution passed by the board of directors. The committee is composed primarily of independent non-executive directors and is tasked with overseeing nominations and appointments within the company. This move is aligned with the company’s commitment to maintaining a robust governance framework and ensuring diverse representation within its leadership. The establishment of the Nomination Committee is expected to enhance the company’s governance practices, potentially improving its industry standing and stakeholder confidence.
Mulsanne Group Holding Limited has announced changes in its board of directors and committee compositions. Mr. YANG Herong has resigned as a non-executive director and member of the remuneration committee, while Mr. CHEN Yeliang has been appointed to these roles. Additionally, Ms. XU Yanyun has joined the nomination committee. These changes are effective from June 30, 2025, and reflect the company’s ongoing efforts to strengthen its governance structure.
Mulsanne Group Holding Limited has announced its board of directors and their respective roles and functions. The announcement outlines the composition of the board, which includes executive, non-executive, and independent non-executive directors, as well as the members of various board committees such as the Audit, Remuneration, and Nomination Committees. This update provides stakeholders with clarity on the governance structure and leadership roles within the company, potentially impacting its strategic direction and operational oversight.
Mulsanne Group Holding Limited held its Annual General Meeting on June 5, 2025, where all proposed resolutions were unanimously passed by shareholders. The resolutions included adopting the company’s financial statements, re-electing directors, re-appointing the auditor, and granting mandates to the directors for share issuance and repurchase. This unanimous approval reflects strong shareholder confidence and supports the company’s strategic initiatives.
Mulsanne Group Holding Limited has announced its upcoming annual general meeting (AGM) to be held on June 5, 2025, in Ningbo, Zhejiang Province, China. Key agenda items include the adoption of the audited financial statements for the year ending December 31, 2024, the re-election of three non-executive directors, and the re-appointment of Ernst & Young as the company’s auditor. Additionally, resolutions will be considered to authorize the board to manage share allotments and related financial instruments, which could impact the company’s capital structure and shareholder value.